ArticleVaccines2024

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine.

Edmund G-T Wee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.